MAZE — Maze Therapeutics, Inc. | XLV Holdings | StockAdder

(MAZE)

Maze Therapeutics, Inc.

Live chart and latest MAZE stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

MAZE News

Maze Therapeutics: MZE829 Presses Forward Despite Stock Price Drop (NASDAQ:MAZE)

Mar 27, 2026 Investor's Business Daily

Why Maze Therapeutics Plunged 35% Despite 'Overwhelming Positive' Data

Mar 25, 2026 TradingView — Track All Markets

MAZE Options Chain — NASDAQ:MAZE

Apr 11, 2026 Yahoo Finance

After Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Maze Therapeutics, Inc. (MAZE)

Mar 27, 2026 Stock Titan

Kidney disease drug cuts proteinuria 35.6% as Maze eyes pivotal study

Mar 25, 2026 Investing.com

Atul Dandekar, CSBO of Maze Therapeutics, sells $220k in Maze stock

Apr 1, 2026 The Motley Fool

Maze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.

Apr 4, 2026 Fierce Biotech

After ph. 2 readout, analysts herald 'best-in-class potential' for Maze kidney candidate as stock plummets

Mar 25, 2026 Zacks Investment Research

Should I buy Maze Therapeutics, Inc. (MAZE)

Mar 27, 2026 TradingView — Track All Markets

MAZE Options Volatility — NASDAQ:MAZE

Apr 11, 2026 Yahoo Finance

Assessing Maze Therapeutics (MAZE) Valuation After Strong Recent Share Price Momentum

Mar 13, 2026 Stock Titan

Director at Maze (NASDAQ: MAZE) receives 33,417 stock options grant

Mar 31, 2026 Stock Titan

Proposed 30,000-share option exercise by MAZE (NASDAQ: MAZE) reported

Mar 30, 2026 Yahoo Finance

We Think Maze Therapeutics (NASDAQ:MAZE) Can Easily Afford To Drive Business Growth

Dec 22, 2025 Investing.com

Maze Therapeutics stock soars 22% on positive trial data for MZE829